Topical TMPRSS2 inhibition prevents SARS-CoV-2 infection in differentiated primary human airway cells
W. Guo, L. M. Porter, T. W. Crozier, M. Coates, A. Jha, M. McKie, J. A. Nathan, P. J. Lehner, E. J. Greenwood, F. McCaughan
This study shows topical camostat mesylate inhibits SARS-CoV-2 infection in human airway cells, suggesting it could be used for pre- or post-exposure prophylaxis.
bioRxiv · Apr 23, 2021Microbiology